Abraxane Plus Cisplatin Compared With Gemcitabine Plus Cisplatin As First- Line Treatment In Patients With Metastatic Triple-Negative Breast Cancer (Gap): A Multicenter, Randomized, Open-Label, Phase Iii Trial
Annals of Oncology（2020）
关键词
cisplatin,breast cancer,gemcitabine,first-line,triple-negative,open-label
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要